Annual Drug Patent Expiration for RHOPRESSA
Rhopressa is a drug marketed by Aerie Pharms Inc and is included in one NDA. It is available from a single supplier. There are thirteen patents protecting this drug.
RHOPRESSA drug price trends.
This drug has sixty patent family members in eleven countries.
The generic ingredient in RHOPRESSA is netarsudil mesylat. One registered supplier for this compound. Additional details are available on netarsudil mesylate’s profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug Aerie Pharms RHOPRESSA